Global Drug Delivery Devices Market Size study & Forecast, by Route of Administration (Injectable, Topical, Ocular, Other Route of Administration), by Application (Cancer, Cardiovascular, Diabetes, Infectious diseases, Other Applications), by End User (Hospitals, Ambulatory Surgical Centers, Other End Users) and Regional Analysis, 2023-2030
Global Drug Delivery Devices Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Drug discovery devices are technological tools and instruments used in the process of discovering and developing new pharmaceutical drugs. These devices are designed to assist researchers and scientists in various stages of the drug discovery pipeline, from target identification and validation to lead optimization and preclinical testing. The Drug Delivery Devices market is expanding because of factors such as the increasing prevalence of chronic diseases, increasing research and development investment for drug devices, and increasing demand for novel drugs.
The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a substantial market for drug discovery devices. There is a need for effective drugs to address these diseases, which drives the demand for drug discovery devices. The rising burden of chronic diseases has fueled the need for innovative drugs, leading to increased investment in drug discovery research and the development of sophisticated drug discovery devices. These devices enhance the efficiency and effectiveness of the drug development process, ultimately benefiting patients by providing better treatment options for chronic diseases. The International Diabetes Federation stated that India has an anticipated 74,194.7 thousand cases of diabetes in 2021, and that figure is expected to increase to 92,973.7 thousand cases by 2030. Furthermore, the Robert Wood Johnson Foundation reports that there were 157 million cases of chronic illness in the United States in 2020, with an expected rise to 171 million cases by 2030. Furthermore, the International Agency for Research on Cancer (IARC), estimated that by the year 2040, there would be around 27.5 million new cases across the globe from 1.9 million new cases in the year 2021. Thus, the rising prevalence of the chronic disease across the globe is driving market growth. Moreover, the expansion of strategic initiative implementation and the creation of new products is fueling the market growth. For instance, in March 2021, researchers from Stanford University and the University of North Carolina at Chapel Hill (UNC) created a 3D-printed vaccine patch that they claim offers superior protection to a conventional vaccine shot. The creation of such innovative items is encouraging the use of medicine delivery products and fostering market expansion. In addition, growing initiatives for technological advancement, increasing development of personalized medicine, favorable government regulations and policies are creating opportunities to the market growth. The BLA is planned to be submitted by the end of Q4 2023. The successful launch of this product may provide patients with an alternative option. However, the high cost of drug delivery devices stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Drug Delivery Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising investment in research and development activities, rising prevalence of various diseases and rising drug development activities in the region. Whereas Asia Pacific is projected to have the significant growth owing to factors such as the rising prevalence of chronic diseases, rising healthcare advancement activities, favorable government initiatives for manufacturing drug delivery devices and rising product launches activities in the region.
Major market player included in this report are:
Pfizer Inc.
Novartis AG
F Hoffmann-La Roche Ltd
Johnson and Johnson Inc.
Bayer AG
Becton, Dickinson and Company
Altaris
Holozymes Inc. (Antares Pharma Inc.)
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd
Recent Developments in the Market:
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Route of Administration:
Injectable
Topical
Ocular
Other Route of Administration
By Application:
Cancer
Cardiovascular
Diabetes
Infectious diseases
Other Applications
By End User:
Hospitals
Ambulatory Surgical Centers
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a substantial market for drug discovery devices. There is a need for effective drugs to address these diseases, which drives the demand for drug discovery devices. The rising burden of chronic diseases has fueled the need for innovative drugs, leading to increased investment in drug discovery research and the development of sophisticated drug discovery devices. These devices enhance the efficiency and effectiveness of the drug development process, ultimately benefiting patients by providing better treatment options for chronic diseases. The International Diabetes Federation stated that India has an anticipated 74,194.7 thousand cases of diabetes in 2021, and that figure is expected to increase to 92,973.7 thousand cases by 2030. Furthermore, the Robert Wood Johnson Foundation reports that there were 157 million cases of chronic illness in the United States in 2020, with an expected rise to 171 million cases by 2030. Furthermore, the International Agency for Research on Cancer (IARC), estimated that by the year 2040, there would be around 27.5 million new cases across the globe from 1.9 million new cases in the year 2021. Thus, the rising prevalence of the chronic disease across the globe is driving market growth. Moreover, the expansion of strategic initiative implementation and the creation of new products is fueling the market growth. For instance, in March 2021, researchers from Stanford University and the University of North Carolina at Chapel Hill (UNC) created a 3D-printed vaccine patch that they claim offers superior protection to a conventional vaccine shot. The creation of such innovative items is encouraging the use of medicine delivery products and fostering market expansion. In addition, growing initiatives for technological advancement, increasing development of personalized medicine, favorable government regulations and policies are creating opportunities to the market growth. The BLA is planned to be submitted by the end of Q4 2023. The successful launch of this product may provide patients with an alternative option. However, the high cost of drug delivery devices stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Drug Delivery Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising investment in research and development activities, rising prevalence of various diseases and rising drug development activities in the region. Whereas Asia Pacific is projected to have the significant growth owing to factors such as the rising prevalence of chronic diseases, rising healthcare advancement activities, favorable government initiatives for manufacturing drug delivery devices and rising product launches activities in the region.
Major market player included in this report are:
Pfizer Inc.
Novartis AG
F Hoffmann-La Roche Ltd
Johnson and Johnson Inc.
Bayer AG
Becton, Dickinson and Company
Altaris
Holozymes Inc. (Antares Pharma Inc.)
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd
Recent Developments in the Market:
- In June 2022, Gufic Biosciences Ltd. introduced Dual Chamber Bags, a revolutionary drug delivery method, at competitive pricing. These dual-chamber IV bags include two chambers and are constructed of polypropylene (DEHP free), with an aluminium foil that could peeled off to store unstable medications that need to be reconstituted right before giving them to the patient.
- In February 2022, The US FDA approved Akeda's TAKHZYRO (lanadelumab-flyo) injectable as a single-dose prefilled syringe (PFS). Using this drug, HAE attacks are be avoided in both adults and children 12 years of age and older.
- Historical Data – 2020 - 2021
- Base Year for Estimation – 2022
- Forecast period - 2023-2030
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered – Route of Administration, Application, End User, Region
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Route of Administration:
Injectable
Topical
Ocular
Other Route of Administration
By Application:
Cancer
Cardiovascular
Diabetes
Infectious diseases
Other Applications
By End User:
Hospitals
Ambulatory Surgical Centers
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Drug Delivery Devices Market, by Region, 2020-2030 (USD Billion)
1.2.2. Drug Delivery Devices Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.3. Drug Delivery Devices Market, by Application, 2020-2030 (USD Billion)
1.2.4. Drug Delivery Devices Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL DRUG DELIVERY DEVICES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL DRUG DELIVERY DEVICES MARKET DYNAMICS
3.1. Drug Delivery Devices Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevelance of chronic diseases
3.1.1.2. Increasing research and development investment
3.1.1.3. Increasing demand for novel drugs
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug Delivery Devices
3.1.3. Market Opportunities
3.1.3.1. Growing initiatives for technological advancement
3.1.3.2. Increasing development of personalized medicine
3.1.3.3. Favourable government regulations and policies
CHAPTER 4. GLOBAL DRUG DELIVERY DEVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION
5.1. Market Snapshot
5.2. Global Drug Delivery Devices Market by Route of Administration, Performance - Potential Analysis
5.3. Global Drug Delivery Devices Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
5.4. Drug Delivery Devices Market, Sub Segment Analysis
5.4.1. Injectable
5.4.2. Topical
5.4.3. Ocular
5.4.4. Other Route of Administration
CHAPTER 6. GLOBAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Drug Delivery Devices Market by Application, Performance - Potential Analysis
6.3. Global Drug Delivery Devices Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Drug Delivery Devices Market, Sub Segment Analysis
6.4.1. Cancer
6.4.2. Cardiovascular
6.4.3. Diabetes
6.4.4. Infectious diseases
6.4.5. Other Applications
CHAPTER 7. GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER
7.1. Market Snapshot
7.2. Global Drug Delivery Devices Market by End User, Performance - Potential Analysis
7.3. Global Drug Delivery Devices Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Drug Delivery Devices Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Other End Users
CHAPTER 8. GLOBAL DRUG DELIVERY DEVICES MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Drug Delivery Devices Market, Regional Market Snapshot
8.4. North America Drug Delivery Devices Market
8.4.1. U.S. Drug Delivery Devices Market
8.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Drug Delivery Devices Market
8.5. Europe Drug Delivery Devices Market Snapshot
8.5.1. U.K. Drug Delivery Devices Market
8.5.2. Germany Drug Delivery Devices Market
8.5.3. France Drug Delivery Devices Market
8.5.4. Spain Drug Delivery Devices Market
8.5.5. Italy Drug Delivery Devices Market
8.5.6. Rest of Europe Drug Delivery Devices Market
8.6. Asia-Pacific Drug Delivery Devices Market Snapshot
8.6.1. China Drug Delivery Devices Market
8.6.2. India Drug Delivery Devices Market
8.6.3. Japan Drug Delivery Devices Market
8.6.4. Australia Drug Delivery Devices Market
8.6.5. South Korea Drug Delivery Devices Market
8.6.6. Rest of Asia Pacific Drug Delivery Devices Market
8.7. Latin America Drug Delivery Devices Market Snapshot
8.7.1. Brazil Drug Delivery Devices Market
8.7.2. Mexico Drug Delivery Devices Market
8.8. Middle East & Africa Drug Delivery Devices Market
8.8.1. Saudi Arabia Drug Delivery Devices Market
8.8.2. South Africa Drug Delivery Devices Market
8.8.3. Rest of Middle East & Africa Drug Delivery Devices Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novartis AG
9.3.3. F Hoffmann-La Roche Ltd
9.3.4. Johnson and Johnson Inc
9.3.5. Bayer AG
9.3.6. Becton, Dickinson and Company
9.3.7. Altaris
9.3.8. Holozymes Inc. (Antares Pharma Inc.)
9.3.9. GlaxoSmithKline PLC
9.3.10. Teva Pharmaceutical Industries Ltd
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Drug Delivery Devices Market, by Region, 2020-2030 (USD Billion)
1.2.2. Drug Delivery Devices Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.3. Drug Delivery Devices Market, by Application, 2020-2030 (USD Billion)
1.2.4. Drug Delivery Devices Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL DRUG DELIVERY DEVICES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL DRUG DELIVERY DEVICES MARKET DYNAMICS
3.1. Drug Delivery Devices Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevelance of chronic diseases
3.1.1.2. Increasing research and development investment
3.1.1.3. Increasing demand for novel drugs
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug Delivery Devices
3.1.3. Market Opportunities
3.1.3.1. Growing initiatives for technological advancement
3.1.3.2. Increasing development of personalized medicine
3.1.3.3. Favourable government regulations and policies
CHAPTER 4. GLOBAL DRUG DELIVERY DEVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION
5.1. Market Snapshot
5.2. Global Drug Delivery Devices Market by Route of Administration, Performance - Potential Analysis
5.3. Global Drug Delivery Devices Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
5.4. Drug Delivery Devices Market, Sub Segment Analysis
5.4.1. Injectable
5.4.2. Topical
5.4.3. Ocular
5.4.4. Other Route of Administration
CHAPTER 6. GLOBAL DRUG DELIVERY DEVICES MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Drug Delivery Devices Market by Application, Performance - Potential Analysis
6.3. Global Drug Delivery Devices Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Drug Delivery Devices Market, Sub Segment Analysis
6.4.1. Cancer
6.4.2. Cardiovascular
6.4.3. Diabetes
6.4.4. Infectious diseases
6.4.5. Other Applications
CHAPTER 7. GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER
7.1. Market Snapshot
7.2. Global Drug Delivery Devices Market by End User, Performance - Potential Analysis
7.3. Global Drug Delivery Devices Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Drug Delivery Devices Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Other End Users
CHAPTER 8. GLOBAL DRUG DELIVERY DEVICES MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Drug Delivery Devices Market, Regional Market Snapshot
8.4. North America Drug Delivery Devices Market
8.4.1. U.S. Drug Delivery Devices Market
8.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Drug Delivery Devices Market
8.5. Europe Drug Delivery Devices Market Snapshot
8.5.1. U.K. Drug Delivery Devices Market
8.5.2. Germany Drug Delivery Devices Market
8.5.3. France Drug Delivery Devices Market
8.5.4. Spain Drug Delivery Devices Market
8.5.5. Italy Drug Delivery Devices Market
8.5.6. Rest of Europe Drug Delivery Devices Market
8.6. Asia-Pacific Drug Delivery Devices Market Snapshot
8.6.1. China Drug Delivery Devices Market
8.6.2. India Drug Delivery Devices Market
8.6.3. Japan Drug Delivery Devices Market
8.6.4. Australia Drug Delivery Devices Market
8.6.5. South Korea Drug Delivery Devices Market
8.6.6. Rest of Asia Pacific Drug Delivery Devices Market
8.7. Latin America Drug Delivery Devices Market Snapshot
8.7.1. Brazil Drug Delivery Devices Market
8.7.2. Mexico Drug Delivery Devices Market
8.8. Middle East & Africa Drug Delivery Devices Market
8.8.1. Saudi Arabia Drug Delivery Devices Market
8.8.2. South Africa Drug Delivery Devices Market
8.8.3. Rest of Middle East & Africa Drug Delivery Devices Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novartis AG
9.3.3. F Hoffmann-La Roche Ltd
9.3.4. Johnson and Johnson Inc
9.3.5. Bayer AG
9.3.6. Becton, Dickinson and Company
9.3.7. Altaris
9.3.8. Holozymes Inc. (Antares Pharma Inc.)
9.3.9. GlaxoSmithKline PLC
9.3.10. Teva Pharmaceutical Industries Ltd
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Drug Delivery Devices Market, report scope
TABLE 2. Global Drug Delivery Devices Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Drug Delivery Devices Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 4. Global Drug Delivery Devices Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Drug Delivery Devices Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 6. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Drug Delivery Devices Market
TABLE 71. List of primary sources, used in the study of global Drug Delivery Devices Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Drug Delivery Devices Market, report scope
TABLE 2. Global Drug Delivery Devices Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Drug Delivery Devices Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 4. Global Drug Delivery Devices Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Drug Delivery Devices Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 6. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Drug Delivery Devices Market
TABLE 71. List of primary sources, used in the study of global Drug Delivery Devices Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Drug Delivery Devices Market, research methodology
FIG 2. Global Drug Delivery Devices Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Drug Delivery Devices Market, key trends 2022
FIG 5. Global Drug Delivery Devices Market, growth prospects 2023-2030
FIG 6. Global Drug Delivery Devices Market, porters 5 force model
FIG 7. Global Drug Delivery Devices Market, pest analysis
FIG 8. Global Drug Delivery Devices Market, value chain analysis
FIG 9. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Drug Delivery Devices Market, regional snapshot 2020 & 2030
FIG 15. North America Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 16. Europe Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Drug Delivery Devices Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Drug Delivery Devices Market, research methodology
FIG 2. Global Drug Delivery Devices Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Drug Delivery Devices Market, key trends 2022
FIG 5. Global Drug Delivery Devices Market, growth prospects 2023-2030
FIG 6. Global Drug Delivery Devices Market, porters 5 force model
FIG 7. Global Drug Delivery Devices Market, pest analysis
FIG 8. Global Drug Delivery Devices Market, value chain analysis
FIG 9. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Drug Delivery Devices Market, regional snapshot 2020 & 2030
FIG 15. North America Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 16. Europe Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Drug Delivery Devices Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Drug Delivery Devices Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
